ClinicalTrials.Veeva

Menu

Different Lung Ultrasound Imaging Protocols in COVID-19 Pneumonia

B

Bursa Yüksek İhtisas Education and Research Hospital

Status

Completed

Conditions

Lung Ultrasound
Covid19
Pneumonia

Treatments

Device: LUS Fourteen area
Device: LUS Twelve area

Study type

Interventional

Funder types

Other

Identifiers

NCT04805684
2011-KAEK-25 2021

Details and patient eligibility

About

Lung ultrasonography (LUS) is also used in COVID 19 pneumonia for diagnostic and follow-up purposes.It has been demonstrated in different studies that it can be used for pathologies in pleural and lung tissue. LUS was applied by different researchers by dividing the lungs into 12 and 14 regions and the results were shared.

Full description

In our study, we aimed to determine the correlation between lung findings of COVID 19 pneumonia and thoracic tomography with the results of LUS applied to different numbers (12 versus 14) of areas.

Enrollment

59 patients

Sex

All

Ages

18 to 85 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • 18 and 85 years old
  • Hospitalized in intensive care unit
  • PCR (polymerase chain reaction) tested
  • Thoracic CT applied

Exclusion criteria

  • Previous lung operation
  • Thoracic wall disorder
  • Interstitial lung disease
  • Patients who did not consent to participate in the study

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

59 participants in 2 patient groups

lung ultrasound 12
Active Comparator group
Description:
12 zone lung ultrasonography protocol
Treatment:
Device: LUS Twelve area
lung ultrasound 14
Active Comparator group
Description:
14 zone lung ultrasonography protocol
Treatment:
Device: LUS Fourteen area

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems